Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC1755952900;52901;52902 chr2:178608208;178608207;178608206chr2:179472935;179472934;179472933
N2AB1591847977;47978;47979 chr2:178608208;178608207;178608206chr2:179472935;179472934;179472933
N2A1499145196;45197;45198 chr2:178608208;178608207;178608206chr2:179472935;179472934;179472933
N2B849425705;25706;25707 chr2:178608208;178608207;178608206chr2:179472935;179472934;179472933
Novex-1861926080;26081;26082 chr2:178608208;178608207;178608206chr2:179472935;179472934;179472933
Novex-2868626281;26282;26283 chr2:178608208;178608207;178608206chr2:179472935;179472934;179472933
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: S
  • RefSeq wild type transcript codon: TCA
  • RefSeq wild type template codon: AGT
  • Domain: Fn3-15
  • Domain position: 90
  • Structural Position: 124
  • Q(SASA): 0.2401
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
S/A rs2055393436 None 0.994 N 0.633 0.188 0.340032825777 gnomAD-4.0.0 1.20032E-05 None None None None N None 0 0 None 0 0 None 0 0 1.3125E-05 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
S/A 0.4944 ambiguous 0.4167 ambiguous -0.615 Destabilizing 0.994 D 0.633 neutral N 0.485808828 None None N
S/C 0.5032 ambiguous 0.3556 ambiguous -0.404 Destabilizing 1.0 D 0.795 deleterious None None None None N
S/D 0.9921 likely_pathogenic 0.9878 pathogenic -0.851 Destabilizing 0.998 D 0.664 prob.neutral None None None None N
S/E 0.9969 likely_pathogenic 0.9956 pathogenic -0.726 Destabilizing 0.998 D 0.676 prob.neutral None None None None N
S/F 0.9944 likely_pathogenic 0.9876 pathogenic -0.385 Destabilizing 0.999 D 0.859 deleterious None None None None N
S/G 0.5697 likely_pathogenic 0.4876 ambiguous -0.987 Destabilizing 0.998 D 0.703 prob.delet. None None None None N
S/H 0.9934 likely_pathogenic 0.9897 pathogenic -1.433 Destabilizing 1.0 D 0.801 deleterious None None None None N
S/I 0.9762 likely_pathogenic 0.956 pathogenic 0.304 Stabilizing 0.999 D 0.848 deleterious None None None None N
S/K 0.9995 likely_pathogenic 0.9993 pathogenic -0.565 Destabilizing 0.998 D 0.663 prob.neutral None None None None N
S/L 0.8956 likely_pathogenic 0.8271 pathogenic 0.304 Stabilizing 0.999 D 0.781 deleterious N 0.479755213 None None N
S/M 0.9345 likely_pathogenic 0.8846 pathogenic 0.29 Stabilizing 1.0 D 0.795 deleterious None None None None N
S/N 0.9683 likely_pathogenic 0.9486 pathogenic -0.92 Destabilizing 0.998 D 0.694 prob.delet. None None None None N
S/P 0.995 likely_pathogenic 0.9896 pathogenic 0.034 Stabilizing 0.999 D 0.84 deleterious N 0.5140813 None None N
S/Q 0.9956 likely_pathogenic 0.9935 pathogenic -0.775 Destabilizing 0.999 D 0.835 deleterious None None None None N
S/R 0.9989 likely_pathogenic 0.9985 pathogenic -0.805 Destabilizing 0.999 D 0.839 deleterious None None None None N
S/T 0.2262 likely_benign 0.1608 benign -0.69 Destabilizing 0.997 D 0.692 prob.delet. N 0.476802751 None None N
S/V 0.9301 likely_pathogenic 0.8815 pathogenic 0.034 Stabilizing 0.999 D 0.836 deleterious None None None None N
S/W 0.9956 likely_pathogenic 0.9931 pathogenic -0.589 Destabilizing 1.0 D 0.884 deleterious None None None None N
S/Y 0.9942 likely_pathogenic 0.9899 pathogenic -0.205 Destabilizing 0.999 D 0.883 deleterious None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.